A Rash Decision: Mycoplasma-Induced Mucositis in a Young Adult
Carlos Fagundo1, Taariq Imami1, Vladimir Valencia1
1Internal Medicine, BayCare Health System, Tampa, USA.
Abstract:
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a distinct emerging clinical entity typically affecting adolescents and adults after a respiratory infection from Mycoplasma pneumoniae. Other known mucocutaneous complications include Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis. We present the case of a 24-year-old male patient who developed fever and cough followed by a rapidly evolving mucocutaneous syndrome characterized by oral mucositis, bilateral conjunctivitis, and vesiculobullous skin lesions affecting the palms, soles, and trunk with no evidence of skin detachment. These findings meet the proposed diagnostic criteria for MIRM. This case highlights the importance of recognizing MIRM as a distinct diagnostic entity to guide targeted antimicrobial therapy and avoid unnecessary morbidity associated with misdiagnosis and inappropriate treatment. Early differentiation from Steven-Johnson syndrome and toxic epidermal necrolysis is critical for optimal patient outcomes.
Insights
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is an emerging condition following respiratory infection. Early recognition of MIRM is crucial for accurate diagnosis and effective treatment, distinguishing it from severe conditions like Stevens-Johnson syndrome.
Area of Science:
- Dermatology
- Infectious Diseases
- Clinical Medicine
Background:
- Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is an emerging clinical entity.
- It typically affects adolescents and adults post-respiratory infection.
- Other mucocutaneous complications include Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis.


